Comparison
2 3 Layered Lissencephaly C5139357 vs 14q24 1q24 3 Microdeletion Syndrome C4750911
Clinical comparison between 2 3 Layered Lissencephaly and 14q24 1q24 3 Microdeletion Syndrome for differential diagnosis and treatment planning.
2 3 Layered Lissencephaly C5139357
A brain malformation where the cerebral cortex develops abnormally with fewer layers. Causes severe developmental delays, seizures, and motor problems. Treatment involves seizure management and developmental support.
14q24 1q24 3 Microdeletion Syndrome C4750911
A rare genetic deletion involving part of chromosome 14. It can affect development and lead to various medical issues. Management focuses on supportive care and addressing specific needs.
6 comparison axes
Onset
2 3 Layered Lissencephaly C5139357
0-1
14q24 1q24 3 Microdeletion Syndrome C4750911
0-null
Onset patterns differ
Severity
2 3 Layered Lissencephaly C5139357
severe
14q24 1q24 3 Microdeletion Syndrome C4750911
moderate
Different severity levels
Chronic
2 3 Layered Lissencephaly C5139357
Chronic
14q24 1q24 3 Microdeletion Syndrome C4750911
Chronic
Differing course
Communicable
2 3 Layered Lissencephaly C5139357
No
14q24 1q24 3 Microdeletion Syndrome C4750911
No
Different transmission
Body System
2 3 Layered Lissencephaly C5139357
neurologic
14q24 1q24 3 Microdeletion Syndrome C4750911
congenital
Same/different system
Category
2 3 Layered Lissencephaly C5139357
neurologic
14q24 1q24 3 Microdeletion Syndrome C4750911
genetic
Different category
Bottom line
2-3-layered-lissencephaly-C5139357 and 14q24-1q24-3-microdeletion-syndrome-C4750911 differ in severity, etiology
Key differentiating points
Findings that most reliably separate the two conditions at the bedside or in the workup.
| Feature | 2 3 Layered Lissencephaly C5139357 | 14q24 1q24 3 Microdeletion Syndrome C4750911 | Discriminating power |
|---|---|---|---|
| Cortical structure | Abnormally layered cerebral cortex, described as 2–3 layers. | No defining cortical-layer pattern is established. | High |
| Neurologic course | Severe developmental delay, seizures, and motor problems are described. | Developmental effects are possible; seizures are not established. | Moderate |
| Genetic basis | Not defined by a chromosome 14 deletion in the source. | Defined by deletion of 14q24.1–q24.3. | High |
When to favor each condition
Choose 2 3 Layered Lissencephaly C5139357 when
Imaging suggests abnormal cortical layering
This matches the described brain malformation better than a deletion label alone.
Moderate
Infant has severe seizures and motor impairment
The source emphasizes an early, severe neurologic presentation.
Moderate
Primary classification is neurologic
The supplied axis places this entity in the neurologic system.
Low
Choose 14q24 1q24 3 Microdeletion Syndrome C4750911 when
Microarray confirms a 14q24.1–q24.3 deletion
The syndrome is defined by that chromosomal deletion.
High
Congenital features occur without proven lissencephaly
The source describes varied congenital and developmental issues.
Moderate
Genetic counseling is the main question
Etiology is chromosomal rather than a named cortical pattern.
Moderate
How key tests differ
| Test | 2 3 Layered Lissencephaly C5139357 | 14q24 1q24 3 Microdeletion Syndrome C4750911 | Interpretation |
|---|---|---|---|
| Brain MRI | May show a lissencephaly or abnormal layering pattern. | No specific MRI finding is established. | Imaging supports the left only when confirmed; it does not diagnose the deletion. |
| Chromosomal microarray | Not required by the supplied definition. | May identify the 14q24.1–q24.3 deletion. | A confirmed deletion supports the right; its absence does not exclude the left. |
| EEG | May be abnormal if seizures occur; no cutoff is established. | Use depends on observed seizures, which are unspecified. | An EEG abnormality is a finding, not a diagnosis of either condition. |
Prognosis comparison
2 3 Layered Lissencephaly C5139357
- Outcome
- A severe chronic neurologic course is described, but individual outcome is not established.
- Factors
- Seizure burden, motor impairment, developmental support, and associated findings.
14q24 1q24 3 Microdeletion Syndrome C4750911
- Outcome
- A moderate chronic course with variable medical issues is suggested.
- Factors
- Deletion confirmation, affected organs, and developmental support.
Time frame: Early-life onset with a chronic course; lifelong predictions are not established.
These labels should not be used to predict mortality or function without assessment.
Complications comparison
| Complication | Presentation |
|---|---|
| Developmental delay | Described as severe. Possible; exact severity is not established. Assess function individually rather than assuming equivalent outcomes. |
| Seizures | Explicitly associated; care is supportive. Not established by the supplied description. Treat observed seizures; do not infer them from the deletion alone. |
| Other medical needs | Primarily neurologic in the source. Various medical issues may occur. Specific complications are not listed and need clinician-directed assessment. |
Patient education highlights
- HighDifferent conditions
One is a cortical malformation; the other is a chromosomal microdeletion. Test results need specialist interpretation.
- HighSupportive care
No cure or medication dose is established here. Care addresses seizures, development, and individual needs.
- MediumGenetics
Genetic counseling may clarify testing and recurrence. Exact risks are not provided.